Search results for “Steroid analog” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 68 patents, we discovered top 15 key players by total patent application. Hollis Eden Pharmaceuticals, BioVie, Inc., NeurMedix, Inc. are dominant in this area. They take 77.94% of the total patent filing.
Hollis Eden Pharmaceuticals
California, United States
Patent: 24
BioVie, Inc.
Massachusetts, United States
Patent: 16
NeurMedix, Inc.
California, United States
Patent: 13
Abbott Laboratories
Illinois, United States
Patent: 7
Harbor Therapeutics, Inc.
California, United States
Patent: 7
Amrad Operations Pty Ltd.
Australia
Patent: 6
Harbor Diversified, Inc.
California, United States
Patent: 4
Pharma Mar SA
Madrid, Spain
Patent: 2
Ciba-Geigy AG
Switzerland
Patent: 2
Schering AG
Berlin, Germany
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3 patents applied in the last 5 years. We discover 1 most active companies in this area.
Emory University
Georgia, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Emory University
Georgia, United States
Patent: 9
Washington University in St. Louis
Missouri, United States
Patent: 4
Ramkhamhaeng University
Thailand
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: